Literature DB >> 11757753

Usefulness of MR imaging in the postsurgical monitoring of gallbladder cancer in a patient with bile duct cancer that developed 7 years after resection of mucinous adenocarcinoma of the gallbladder.

S Takai1, Y Shiratori, M Kanematsu, K Yamazaki, T Naiki, I Yasuda, M Nagaki, N Murakami, T Kato, H Takao, K Shimokawa, H Hoshi, S Saji, H Moriwaki.   

Abstract

We encountered a case of left hepatic duct cancer that developed 7 years after surgical resection of early-stage adenocarcinoma of the gallbladder. A 65-year-old woman was hospitalized with high fever and general fatigue. She also had elevated serum levels of alkaline phosphatase, gamma-glutamyltranspeptidase, and carbohydrate antigen 19-9. Seven years earlier, she had undergone extended cholecystectomy and resection of the extrahepatic bile duct for early-stage mucinous adenocarcinoma of the gallbladder. Conventional examinations did not reveal any responsible lesions. Magnetic resonance (MR) cholangiography, however, showed a tumor obstructing the left hepatic duct, and dynamic MR images revealed multiple foci of bacterial abscess in the liver. Surgically resected tissue again revealed mucinous adenocarcinoma. The present case is rare in that metachronous mucinous adenocarcinoma of the biliary system occurred after a long interval. This case suggests the usefulness of MR imaging in the postsurgical monitoring of patients with gallbladder carcinoma.

Entities:  

Mesh:

Year:  2001        PMID: 11757753     DOI: 10.1007/s005350170023

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  2 in total

1.  Metachronous bile duct cancer nine years after resection of gallbladder cancer.

Authors:  Hye Jin Joo; Gi Hyun Kim; Won Joong Jeon; Hee Bok Chae; Seon Mee Park; Sei Jin Youn; Jae Woon Choi; Rohyun Sung
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

2.  Metachronous biliary carcinoma with intraductal pancreatic adenocarcinoma 13 years after curative resection of hilar bile duct cancer.

Authors:  Hisatsugu Maekawa; Takahisa Fujikawa; Akira Tanaka
Journal:  BMJ Case Rep       Date:  2014-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.